HALBERD CORPORATION
https://halberdcorporation.com/
Email: support@halberdcorporation.com
HALB Security Details - https://www.otcmarkets.com/stock/HALB/security
Share Structure
Authorized Shares - 800,000,000 - a/o 01/19/2022
Shares Outstanding - 511,621,968 - a/o 01/19/2022
Float- 320,542,712 - a/o 10/31/2021
Halberd Corp. (OTC PINK:HALB), is a publicly traded company on the OTC Market, and is in full compliance with OTC Market reporting requirements.
HALB holds the exclusive rights to 3 granted U.S. Patents, no. 9,216,386 no. 8,758,287 and no. 11,186,629
See YouTube video, https://youtu.be/BGdZqHH6oew, concerning Dr. Felder’s discussion of the scientific basis underlying Premier’s extracorporeal treatment process for fighting cancer and other diseases.
In plain English: HALB with its partners is developing an extra-corporeal (out of the body) treatment against Alzheimer's Disease and other virusses and diseases. With the use of antibodies the diseases antigens are targeted. Using radiofrequency / laser technology antigens and cytokines are eradicated. All based on 3 granted patents and 16 (per 11/23/2021) provisional patent applications.
Halberd Corporation's Proprietary Technology for Alzheimer's Disease Enters Stage 4 of 7 Stage Process
Jackson Center, Pennsylvania--(Newsfile Corp. - June 21, 2021) - Halberd Corporation's (OTC Pink: HALB) proprietary technology enters stage 4 to address Alzheimer's Disease (and other potential diseases), eradicating the antibody-disease combination through radiofrequency waves or laser or other means. Currently, there is no known effective treatment for Alzheimer's Disease which afflicts over 40 million people worldwide, equivalent to the combined population of the states of Florida and New York.
The seven (7) stages in Halberd's program are as follows:
- 1. Identifying target disease(s); (Done)
2. Creating patentable antibodies vs target disease(s); (Done)
3. Combining antibodies with metallic particles; (Done)
4. Eradicating the antibody-disease combination through radiofrequency waves, laser or other proprietary means; (In-process)
5. Conducting animal tests to establish the safety and efficacy; (Preliminary Planning)
6. Conducting human testing
7. Obtaining FDA Certification
Halberd Corporation Successfully Establishes Disease Eradication Proof-of-Concept - "Never Before Accomplished"
https://www.accesswire.com/652434/Halberd-Corporations-Proprietary-Technology-for-Alzheimers-Disease-Enters-Stage-4-of-7-Stage-Process 
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________